Literature DB >> 22322302

Macrophage β2 integrin-mediated, HuR-dependent stabilization of angiogenic factor-encoding mRNAs in inflammatory angiogenesis.

Jiange Zhang1, Yasha Modi, Timur Yarovinsky, Jun Yu, Mark Collinge, Themis Kyriakides, Yizhun Zhu, William C Sessa, Ruggero Pardi, Jeffrey R Bender.   

Abstract

HuR is a member of the Drosophila Elav protein family that binds mRNA degradation sequences and prevents RNase-mediated degradation. Such HuR-mediated mRNA stabilization, which is stimulated by integrin engagement and is controlled at the level of HuR nuclear export, is critically involved in T-cell cytokine production. However, HuR's role in macrophage soluble factor production, in particular in response to angiogenic stimuli, has not yet been established. We show that the labile transcripts that encode vascular endothelial growth factor and matrix metalloproteinase-9 are stabilized when murine macrophages adhere to the β(2) integrin ligand intercellular adhesion molecule-1. This mRNA stabilization response was absent in bone marrow-derived macrophages obtained from conditional macrophage-specific HuR knockout mice. The microvascular angiogenic response to an inflammatory stimulus (ie, subcutaneous polyvinyl alcohol sponge implantation) was markedly diminished in these macrophage HuR knockout mice despite the equal levels of macrophage localization to those observed in littermate wild-type controls. Furthermore, blood flow recovery and ischemic muscle neovascularization after femoral artery ligation were impaired in the conditional macrophage-specific HuR knockout mice. These results demonstrate that dynamic effects on mRNA, mediated by the RNA-binding and RNA-stabilizing protein HuR, are required for macrophage production of angiogenic factors, which play critical roles in the neovascular responses to a variety of stimuli, including tissue ischemia.
Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22322302      PMCID: PMC3349897          DOI: 10.1016/j.ajpath.2011.12.025

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  42 in total

Review 1.  Mechanisms of angiogenesis and arteriogenesis.

Authors:  P Carmeliet
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

2.  Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs.

Authors:  X C Fan; J A Steitz
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

3.  Differential roles of macrophages in diverse phases of skin repair.

Authors:  Tina Lucas; Ari Waisman; Rajeev Ranjan; Jürgen Roes; Thomas Krieg; Werner Müller; Axel Roers; Sabine A Eming
Journal:  J Immunol       Date:  2010-02-22       Impact factor: 5.422

4.  Identification of HuR as a protein implicated in AUUUA-mediated mRNA decay.

Authors:  V E Myer; X C Fan; J A Steitz
Journal:  EMBO J       Date:  1997-04-15       Impact factor: 11.598

5.  Matrix metalloproteinase-9 is required for adequate angiogenic revascularization of ischemic tissues: potential role in capillary branching.

Authors:  Chad Johnson; Hak-Joon Sung; Susan M Lessner; M Elizabeth Fini; Zorina S Galis
Journal:  Circ Res       Date:  2003-12-11       Impact factor: 17.367

6.  Molecular evidence for induction of intracellular adhesion molecule-1 in the viable border zone associated with ischemia-reperfusion injury of the dog heart.

Authors:  K A Youker; H K Hawkins; G L Kukielka; J L Perrard; L H Michael; C M Ballantyne; C W Smith; M L Entman
Journal:  Circulation       Date:  1994-06       Impact factor: 29.690

7.  Angiopoietin-2 stimulates blood flow recovery after femoral artery occlusion by inducing inflammation and arteriogenesis.

Authors:  Sarah L Tressel; Hyongbum Kim; Chih-Wen Ni; Kyunghwa Chang; Juan C Velasquez-Castano; W Robert Taylor; Young-Sup Yoon; Hanjoong Jo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-09-04       Impact factor: 8.311

Review 8.  Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages.

Authors:  C E Lewis; R Leek; A Harris; J O McGee
Journal:  J Leukoc Biol       Date:  1995-05       Impact factor: 4.962

9.  A transgenic mouse model of inducible macrophage depletion: effects of diphtheria toxin-driven lysozyme M-specific cell lineage ablation on wound inflammatory, angiogenic, and contractive processes.

Authors:  Itamar Goren; Nadine Allmann; Nir Yogev; Christoph Schürmann; Andreas Linke; Martin Holdener; Ari Waisman; Josef Pfeilschifter; Stefan Frank
Journal:  Am J Pathol       Date:  2009-06-15       Impact factor: 4.307

10.  T cell LFA-1 engagement induces HuR-dependent cytokine mRNA stabilization through a Vav-1, Rac1/2, p38MAPK and MKK3 signaling cascade.

Authors:  Vinod S Ramgolam; Scott D DeGregorio; Gautham K Rao; Mark Collinge; Sharmila S Subaran; Silva Markovic-Plese; Ruggero Pardi; Jeffrey R Bender
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240

View more
  25 in total

1.  Hu-antigen receptor (HuR) and cyclooxygenase-2 (COX-2) expression in human non-small-cell lung carcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survival.

Authors:  Constantinos Giaginis; Paraskevi Alexandrou; Nikolaos Tsoukalas; Ioannis Sfiniadakis; Nikolaos Kavantzas; Emmanuel Agapitos; Efstratios Patsouris; Stamatios Theocharis
Journal:  Tumour Biol       Date:  2014-09-25

2.  Elevated Hu-Antigen Receptor (HuR) Expression is Associated with Tumor Aggressiveness and Poor Prognosis but not with COX-2 Expression in Invasive Breast Carcinoma Patients.

Authors:  Constantinos Giaginis; Anastasia Sampani; Iolly Kotta-Loizou; Ioanna Giannopoulou; Eugene Danas; Ekaterini Politi; Gerasimos Tsourouflis; Gregorios Kouraklis; Efstratios Patsouris; Antonios Keramopoulos; Lydia Nakopoulou; Stamatios Theocharis
Journal:  Pathol Oncol Res       Date:  2017-08-14       Impact factor: 3.201

Review 3.  Post-transcriptional coordination of immunological responses by RNA-binding proteins.

Authors:  Panagiota Kafasla; Antonis Skliris; Dimitris L Kontoyiannis
Journal:  Nat Immunol       Date:  2014-06       Impact factor: 25.606

Review 4.  Clinical significance of HuR expression in human malignancy.

Authors:  Ioly Kotta-Loizou; Constantinos Giaginis; Stamatios Theocharis
Journal:  Med Oncol       Date:  2014-08-13       Impact factor: 3.064

5.  ELAVL1 regulates alternative splicing of eIF4E transporter to promote postnatal angiogenesis.

Authors:  Sung-Hee Chang; Olivier Elemento; Jiasheng Zhang; Zhen W Zhuang; Michael Simons; Timothy Hla
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-24       Impact factor: 11.205

Review 6.  RNA-stabilizing proteins as molecular targets in cardiovascular pathologies.

Authors:  Sahana Suresh Babu; Darukeshwara Joladarashi; Prince Jeyabal; Rajarajan A Thandavarayan; Prasanna Krishnamurthy
Journal:  Trends Cardiovasc Med       Date:  2015-02-20       Impact factor: 6.677

7.  Antagonistic function of the RNA-binding protein HuR and miR-200b in post-transcriptional regulation of vascular endothelial growth factor-A expression and angiogenesis.

Authors:  Sung-Hee Chang; Yi-Chien Lu; Xi Li; Wan-Ying Hsieh; Yuquan Xiong; Mallika Ghosh; Todd Evans; Olivier Elemento; Timothy Hla
Journal:  J Biol Chem       Date:  2012-12-06       Impact factor: 5.157

8.  ELAVL1 modulates transcriptome-wide miRNA binding in murine macrophages.

Authors:  Yi-Chien Lu; Sung-Hee Chang; Markus Hafner; Xi Li; Thomas Tuschl; Olivier Elemento; Timothy Hla
Journal:  Cell Rep       Date:  2014-12-18       Impact factor: 9.423

Review 9.  HuR: a promising therapeutic target for angiogenesis.

Authors:  Rui Dong; Guo-Dong Yang; Nian-An Luo; Ya-Qi Qu
Journal:  Gland Surg       Date:  2014-08

Review 10.  Post-transcriptional regulation of cytokine and growth factor signaling in cancer.

Authors:  Irina Vlasova-St Louis; Paul R Bohjanen
Journal:  Cytokine Growth Factor Rev       Date:  2016-12-02       Impact factor: 7.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.